Lipocalin 2 as a potential liquid biopsy marker for early detection of bladder cancer

Mi-So Jeong; Jeong-Yeon Mun; Gi-Eun Yang; Seung-Woo Baek; Sang-Yeop Lee; Sung Ho Yun; Seung Il Kim; Jae-Jun Kim; Seo-Yeong Yoon; Jong-Kil Nam; Yung-Hyun Choi; Hyeok Jun Goh; Tae-Nam Kim; Sun-Hee Leem

doi:10.1002/ctm2.70540

Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (12) :e70540 DOI: 10.1002/ctm2.70540

LETTER TO THE JOURNAL

Lipocalin 2 as a potential liquid biopsy marker for early detection of bladder cancer

Author information +

¹. Department of Biomedical Sciences, Dong-A University, Busan, South Korea

². Research Center, Dongnam Institute of Radiological & Medical Sciences, Busan, South Korea

³. Department of Pathology and Cell Biology, Columbia University Medical Center, New York, New York, USA

⁴. Department of Health Sciences, The Graduated of Dong-A University, Busan, South Korea

⁵. Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea

⁶. Research Center for Bioconvergence Analysis, Korea Basic Science Institute, Ochang, South Korea

⁷. Center for Research Equipment, Korea Basic Science Institute, Ochang, South Korea

⁸. Department of Urology, Pusan National University Yangsan Hospital, Pusan National University School of Medicine, Research Institute for Convergence of Biomedical Science and Technology, Yangsan, South Korea

⁹. Department of Biochemistry, College of Oriental Medicine, Anti-Aging Research Center, Dong-eui University, Busan, South Korea

¹⁰. Department of Urology, Dong-A University College of Medicine, Busan, South Korea

¹¹. Department of Urology, Pusan National University Hospital, Pusan National University School of Medicine, Biomedical Research Institute and Pusan National University Hospital, Busan, South Korea

bigman1995@hanmail.net

shleem@dau.ac.kr

Show less

History +

PDF

Cite this article

Download citation ▾

Mi-So Jeong, Jeong-Yeon Mun, Gi-Eun Yang, Seung-Woo Baek, Sang-Yeop Lee, Sung Ho Yun, Seung Il Kim, Jae-Jun Kim, Seo-Yeong Yoon, Jong-Kil Nam, Yung-Hyun Choi, Hyeok Jun Goh, Tae-Nam Kim, Sun-Hee Leem. Lipocalin 2 as a potential liquid biopsy marker for early detection of bladder cancer. Clinical and Translational Medicine, 2025, 15(12): e70540 DOI:10.1002/ctm2.70540

登录浏览全文

4963

注册一个新账户忘记密码

References

Publishing order | Descend order by publishing year | Descend order by cited within

[1]	Crocetto F, Amicuzi U, Musone M, et al. Liquid biopsy: current advancements in clinical practice for bladder cancer. J Liq Biopsy. 2025; 9:100310.

[2]	Babjuk M, Burger M, Capoun O, et al. European Association of Urology Guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol. 2022; 81(1): 75-94.

[3]	Crocetto F, Barone B, Ferro M, et al. Liquid biopsy in bladder cancer: state of the art and future perspectives. Crit Rev Oncol Hematol. 2022; 170:103577.

[4]	Jeong MS, Baek SW, Yang GE, et al. Chemoresistance-motility signature of molecular evolution to chemotherapy in non-muscle-invasive bladder cancer and its clinical implications. Cancer Lett. 2025;610:217339.

[5]	Santiago-Sanchez GS, Pita-Grisanti V, Quinones-Diaz B, Gumpper K, Cruz-Monserrate Z, Vivas-Mejia PE. Biological functions and therapeutic potential of lipocalin 2 in cancer. Int J Mol Sci. 2020; 21(12): 4365.

[6]	Provatopoulou X, Gounaris A, Kalogera E, et al. Circulating levels of matrix metalloproteinase-9 (MMP-9), neutrophil gelatinase-associated lipocalin (NGAL) and their complex MMP-9/NGAL in breast cancer disease. BMC Cancer. 2009; 9: 390.

[7]	Candido S, Di Maso M, Serraino D, et al. Diagnostic value of neutrophil gelatinase-associated lipocalin/matrix metalloproteinase-9 pathway in transitional cell carcinoma of the bladder. Tumour Biol. 2016; 37(7): 9855-9863.

[8]	Song Y, Na H, Lee SE, et al. Dysfunctional adipocytes promote tumor progression through YAP/TAZ-dependent cancer-associated adipocyte transformation. Nat Commun. 2024; 15(1): 4052.

[9]	Lindskrog SV, Prip F, Lamy P, et al. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat Commun. 2021; 12(1): 2301.

[10]	Liu ZL, Chen HH, Zheng LL, Sun LP, Shi L. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduct Target Ther. 2023; 8(1): 198.

RIGHTS & PERMISSIONS

2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.